The limitations of targeting MEK signalling in Glioblastoma therapy.
Selvasaravanan KD, Wiederspohn N, Hadzalic A, Strobel H, Payer C, Schuster A, Karpel-Massler G, Siegelin MD, Halatsch ME, Debatin KM, Westhoff MA.
Selvasaravanan KD, et al. Among authors: schuster a.
Sci Rep. 2020 May 4;10(1):7401. doi: 10.1038/s41598-020-64289-6.
Sci Rep. 2020.
PMID: 32366879
Free PMC article.